Skip to main content
Erschienen in: International Urogynecology Journal 2/2007

01.02.2007 | Review Article

Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy

verfasst von: Christopher R. Chapple, Linda Brubaker, François Haab, Philip van Kerrebroeck, Dudley Robinson

Erschienen in: International Urogynecology Journal | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Intervention for stress urinary incontinence (SUI) is generally focused on minimizing urinary leakage. However, the overall impact of SUI therapy on patients’ quality of life is, arguably, more important than leakage outcomes. We performed a literature search to investigate the effect of urethral injection therapy on quality of life. Significant quality-of-life improvements have been observed with a number of injectable agents, while there is a distinct lack of correlation between subjective and objective outcomes. Two studies comparing urethral injection therapy with surgical intervention found superior objective efficacy with surgery, but no significant differences in quality-of-life improvements. Personal goals of patients undergoing urethral injection are yet to be explored, but there may be willingness to trade a lower success rate in favor of a more minor treatment procedure. In conclusion, quality-of-life improvements after urethral injection appear significant and comparable to those obtained with surgery. Further study of patients’ own perceptions, pre- and posttreatment, would be valuable.
Literatur
1.
Zurück zum Zitat Ware JE, Snow KK, Kosinski M, Gandek B (1993) SF-36 Health Survey: manual and interpretation guide. The Health Institute, New England Medical Center, Boston Ware JE, Snow KK, Kosinski M, Gandek B (1993) SF-36 Health Survey: manual and interpretation guide. The Health Institute, New England Medical Center, Boston
2.
Zurück zum Zitat Kelleher CJ, Pleil AM, Reese PR, Burgess SM, Brodish PH (2004) How much is enough and who says so? BJOG 111:605–612PubMedCrossRef Kelleher CJ, Pleil AM, Reese PR, Burgess SM, Brodish PH (2004) How much is enough and who says so? BJOG 111:605–612PubMedCrossRef
3.
Zurück zum Zitat Patrick DL, Martin ML, Bushnell DM, Yalcin I, Wagner TH et al (1999) Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL). Urology 53:71–76PubMedCrossRef Patrick DL, Martin ML, Bushnell DM, Yalcin I, Wagner TH et al (1999) Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL). Urology 53:71–76PubMedCrossRef
4.
Zurück zum Zitat Bent AE, Foote J, Siegel S, Faerber G, Chao R et al (2001) Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol 166:1354–1357PubMedCrossRef Bent AE, Foote J, Siegel S, Faerber G, Chao R et al (2001) Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol 166:1354–1357PubMedCrossRef
5.
Zurück zum Zitat Winters JC, Chiverton A, Scarpero HM, Prats LJ Jr (2000) Collagen injection therapy in elderly women: long-term results and patient satisfaction. Urology 55:856–861PubMedCrossRef Winters JC, Chiverton A, Scarpero HM, Prats LJ Jr (2000) Collagen injection therapy in elderly women: long-term results and patient satisfaction. Urology 55:856–861PubMedCrossRef
6.
Zurück zum Zitat Poon CI, Zimmern PE, Wilson TS, Defreitas GA, Foreman MR (2005) Three-dimensional ultrasonography to assess long-term durability of periurethral collagen in women with stress urinary incontinence due to intrinsic sphincter deficiency. Urology 65:60–64PubMedCrossRef Poon CI, Zimmern PE, Wilson TS, Defreitas GA, Foreman MR (2005) Three-dimensional ultrasonography to assess long-term durability of periurethral collagen in women with stress urinary incontinence due to intrinsic sphincter deficiency. Urology 65:60–64PubMedCrossRef
7.
Zurück zum Zitat Fianu-Jonasson A, Larsson G, Farrelly E (2005) The Zuidex system for the treatment of stress urinary incontinence: 36-month follow-up. Abstract no. 617. In: International Continence Society (ICS) 35th annual meeting, Montreal, Canada, 28 August–2 September 2005 Fianu-Jonasson A, Larsson G, Farrelly E (2005) The Zuidex system for the treatment of stress urinary incontinence: 36-month follow-up. Abstract no. 617. In: International Continence Society (ICS) 35th annual meeting, Montreal, Canada, 28 August–2 September 2005
8.
Zurück zum Zitat van Kerrebroeck P, ter Meulen F, Larsson G, Farrelly E, Edwall L et al (2004) Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence. Urology 64:276–281PubMedCrossRef van Kerrebroeck P, ter Meulen F, Larsson G, Farrelly E, Edwall L et al (2004) Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence. Urology 64:276–281PubMedCrossRef
9.
Zurück zum Zitat Chapple C, Haab F, Cervigni M, Dannecker C, Fianu-Jonasson A et al (2005) An open, multicentre study of NASHA/Dx gel via the Implacer for the treatment of stress urinary incontinence. Eur Urol 48:488–494PubMed Chapple C, Haab F, Cervigni M, Dannecker C, Fianu-Jonasson A et al (2005) An open, multicentre study of NASHA/Dx gel via the Implacer for the treatment of stress urinary incontinence. Eur Urol 48:488–494PubMed
10.
Zurück zum Zitat Tamanini JT, D’Ancona CA, Netto NR Jr (2004) Treatment of intrinsic sphincter deficiency using the Macroplastique Implantation System: two-year follow-up. J Endourol 18:906–911PubMedCrossRef Tamanini JT, D’Ancona CA, Netto NR Jr (2004) Treatment of intrinsic sphincter deficiency using the Macroplastique Implantation System: two-year follow-up. J Endourol 18:906–911PubMedCrossRef
11.
Zurück zum Zitat Kothari S, Pitkin J (2002) Efficacy of periurethral silicone implants (Macroplastique) in the treatment of urinary stress incontinence and stress incontinence with detrusor overactivity—a questionnaire study. Abstract 280. In: Annual Meeting of the International Continence Society, Heidelberg, Germany, 28–30 August 2002 Kothari S, Pitkin J (2002) Efficacy of periurethral silicone implants (Macroplastique) in the treatment of urinary stress incontinence and stress incontinence with detrusor overactivity—a questionnaire study. Abstract 280. In: Annual Meeting of the International Continence Society, Heidelberg, Germany, 28–30 August 2002
12.
Zurück zum Zitat Anders K, Khullar V, Cardozo L, Bidmead J, Athanasiou S et al (2002) Contigen or Macroplastique? A five-year follow-up. Abstract 281. In: Annual Meeting of the International Continence Society, Heidelberg, Germany, 28–30 August 2002 Anders K, Khullar V, Cardozo L, Bidmead J, Athanasiou S et al (2002) Contigen or Macroplastique? A five-year follow-up. Abstract 281. In: Annual Meeting of the International Continence Society, Heidelberg, Germany, 28–30 August 2002
13.
Zurück zum Zitat Dmochowski R, Herschorn S, Corcos J, Radomski S, Pommerville P et al (2003) Multicenter randomized controlled study to evaluate Uryx® urethral bulking agent in treating female stress urinary incontinence. Abstract 341. In: 33rd Annual Meeting of the International Continence Society, Florence, Italy, 5–9 October 2003 Dmochowski R, Herschorn S, Corcos J, Radomski S, Pommerville P et al (2003) Multicenter randomized controlled study to evaluate Uryx® urethral bulking agent in treating female stress urinary incontinence. Abstract 341. In: 33rd Annual Meeting of the International Continence Society, Florence, Italy, 5–9 October 2003
14.
Zurück zum Zitat Bano F, Barrington JW, Dyer R (2005) Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct 16:147–150PubMedCrossRef Bano F, Barrington JW, Dyer R (2005) Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct 16:147–150PubMedCrossRef
15.
Zurück zum Zitat Corcos J, Collet JP, Shapiro S, Herschorn S, Radomski SB et al (2005) Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence. Urology 65:898–904PubMedCrossRef Corcos J, Collet JP, Shapiro S, Herschorn S, Radomski SB et al (2005) Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence. Urology 65:898–904PubMedCrossRef
16.
Zurück zum Zitat Maher CF, O'Reilly BA, Dwyer PL, Carey MP, Cornish A et al (2005) Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial. BJOG 112:797–801PubMedCrossRef Maher CF, O'Reilly BA, Dwyer PL, Carey MP, Cornish A et al (2005) Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial. BJOG 112:797–801PubMedCrossRef
17.
Zurück zum Zitat Steele AC, Kohli N, Karram MM (2000) Periurethral collagen injection for stress incontinence with and without urethral hypermobility. Obstet Gynecol 95:327–331PubMedCrossRef Steele AC, Kohli N, Karram MM (2000) Periurethral collagen injection for stress incontinence with and without urethral hypermobility. Obstet Gynecol 95:327–331PubMedCrossRef
18.
Zurück zum Zitat Chrouser KL, Fick F, Goel A, Itano NB, Sweat SD et al (2004) Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended follow-up. J Urol 171:1152–1155PubMedCrossRef Chrouser KL, Fick F, Goel A, Itano NB, Sweat SD et al (2004) Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended follow-up. J Urol 171:1152–1155PubMedCrossRef
19.
Zurück zum Zitat van Kerrebroeck P, ter Meulen F, Larsson G, Farrelly E, Edwall L et al (2004) Treatment of stress urinary incontinence using a copolymer system: impact on quality of life. BJU Int 94:1040–1043PubMedCrossRef van Kerrebroeck P, ter Meulen F, Larsson G, Farrelly E, Edwall L et al (2004) Treatment of stress urinary incontinence using a copolymer system: impact on quality of life. BJU Int 94:1040–1043PubMedCrossRef
20.
Zurück zum Zitat Madjar S, Covington-Nichols C, Secrest CL (2003) New periurethral bulking agent for stress urinary incontinence: modified technique and early results. J Urol 170:2327–2329PubMedCrossRef Madjar S, Covington-Nichols C, Secrest CL (2003) New periurethral bulking agent for stress urinary incontinence: modified technique and early results. J Urol 170:2327–2329PubMedCrossRef
21.
Zurück zum Zitat Chapple C, Wein A, Brubaker L, Dmochowski R, Espuña Pons M et al (2005) Stress incontinence injection therapy: what is best for our patients? Eur Urol 48:552–565PubMedCrossRef Chapple C, Wein A, Brubaker L, Dmochowski R, Espuña Pons M et al (2005) Stress incontinence injection therapy: what is best for our patients? Eur Urol 48:552–565PubMedCrossRef
22.
Zurück zum Zitat Lightner D, Calvosa C, Andersen R, Klimberg I, Brito CG et al (2001) A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology 58:12–15PubMedCrossRef Lightner D, Calvosa C, Andersen R, Klimberg I, Brito CG et al (2001) A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology 58:12–15PubMedCrossRef
23.
Zurück zum Zitat Kershen RT, Appell RA (2002) De novo urge syndrome and detrusor instability after anti-incontinence surgery: current concepts, evaluation, and treatment. Curr Urol Rep 3:345–353PubMed Kershen RT, Appell RA (2002) De novo urge syndrome and detrusor instability after anti-incontinence surgery: current concepts, evaluation, and treatment. Curr Urol Rep 3:345–353PubMed
24.
Zurück zum Zitat Chaliha C, Stanton SL (1999) Complications of surgery for genuine stress incontinence. BJOG 106:1238–1245CrossRef Chaliha C, Stanton SL (1999) Complications of surgery for genuine stress incontinence. BJOG 106:1238–1245CrossRef
25.
Zurück zum Zitat Elkadry EA, Kenton KS, FitzGerald MP, Shott S, Brubaker L (2003) Patient-selected goals: a new perspective on surgical outcome. Am J Obstet Gynecol 189:1551–1557PubMedCrossRef Elkadry EA, Kenton KS, FitzGerald MP, Shott S, Brubaker L (2003) Patient-selected goals: a new perspective on surgical outcome. Am J Obstet Gynecol 189:1551–1557PubMedCrossRef
26.
Zurück zum Zitat Mahajan ST, Elkadry EA, Shott S, Kenton K, Brubaker L (2006) Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol 194:722–728PubMedCrossRef Mahajan ST, Elkadry EA, Shott S, Kenton K, Brubaker L (2006) Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol 194:722–728PubMedCrossRef
27.
Zurück zum Zitat Robinson D, Anders K, Cardozo L, Bidmead J, Dixon A et al (2003) What do women want? Interpretation of the concept of cure. J Pelvic Med Surg 9:273–277CrossRef Robinson D, Anders K, Cardozo L, Bidmead J, Dixon A et al (2003) What do women want? Interpretation of the concept of cure. J Pelvic Med Surg 9:273–277CrossRef
28.
Zurück zum Zitat Dmochowski RR, Appell RA (2000) Injectable agents in the treatment of stress urinary incontinence in women: where are we now? Urology 56:32–40PubMedCrossRef Dmochowski RR, Appell RA (2000) Injectable agents in the treatment of stress urinary incontinence in women: where are we now? Urology 56:32–40PubMedCrossRef
29.
Zurück zum Zitat Lightner DJ, Itano NB, Sweat SD, Chrouser KL, Fick F (2002) Injectable agents: present and future. Curr Urol Rep 3:408–413PubMed Lightner DJ, Itano NB, Sweat SD, Chrouser KL, Fick F (2002) Injectable agents: present and future. Curr Urol Rep 3:408–413PubMed
30.
Zurück zum Zitat Khullar V, Cardozo LD, Abbott D, Anders K (1997) GAX collagen in the treatment of urinary incontinence in elderly women: a two year follow up. BJOG 104:96–99CrossRef Khullar V, Cardozo LD, Abbott D, Anders K (1997) GAX collagen in the treatment of urinary incontinence in elderly women: a two year follow up. BJOG 104:96–99CrossRef
31.
Zurück zum Zitat Hartanto VH, Lightner DJ, Nitti VW (2003) Endoscopic evacuation of Durasphere. Urology 62:135–137PubMedCrossRef Hartanto VH, Lightner DJ, Nitti VW (2003) Endoscopic evacuation of Durasphere. Urology 62:135–137PubMedCrossRef
32.
Zurück zum Zitat McKinney CD, Gaffey MJ, Gillenwater JY (1995) Bladder outlet obstruction after multiple periurethral polytetrafluoroethylene injections. J Urol 153:149–151PubMedCrossRef McKinney CD, Gaffey MJ, Gillenwater JY (1995) Bladder outlet obstruction after multiple periurethral polytetrafluoroethylene injections. J Urol 153:149–151PubMedCrossRef
33.
Zurück zum Zitat Sweat SD, Lightner DJ (1999) Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents. J Urol 161:93–96PubMedCrossRef Sweat SD, Lightner DJ (1999) Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents. J Urol 161:93–96PubMedCrossRef
34.
Zurück zum Zitat Barranger E, Fritel X, Kadoch O, Liou Y, Pigne A (2000) Results of transurethral injection of silicone micro-implants for females with intrinsic sphincter deficiency. J Urol 164:1619–1622PubMedCrossRef Barranger E, Fritel X, Kadoch O, Liou Y, Pigne A (2000) Results of transurethral injection of silicone micro-implants for females with intrinsic sphincter deficiency. J Urol 164:1619–1622PubMedCrossRef
35.
Zurück zum Zitat Janowsky EC, Kupper LL, Hulka BS (2000) Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 342:781–790PubMedCrossRef Janowsky EC, Kupper LL, Hulka BS (2000) Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 342:781–790PubMedCrossRef
36.
Zurück zum Zitat Henly DR, Barrett DM, Weiland TL, O’Connor MK, Malizia AA et al (1995) Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol 153:2039–2043PubMedCrossRef Henly DR, Barrett DM, Weiland TL, O’Connor MK, Malizia AA et al (1995) Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol 153:2039–2043PubMedCrossRef
37.
Zurück zum Zitat Pannek J, Brands FH, Senge T (2001) Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence. J Urol 166:1350–1353PubMedCrossRef Pannek J, Brands FH, Senge T (2001) Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence. J Urol 166:1350–1353PubMedCrossRef
38.
Zurück zum Zitat Stenberg AM, Larsson G, Johnson P (2003) Urethral injection for stress urinary incontinence: long-term results with dextranomer/hyaluronic acid copolymer. Int Urogynecol J Pelvic Floor Dysfunct 14:335–338PubMedCrossRef Stenberg AM, Larsson G, Johnson P (2003) Urethral injection for stress urinary incontinence: long-term results with dextranomer/hyaluronic acid copolymer. Int Urogynecol J Pelvic Floor Dysfunct 14:335–338PubMedCrossRef
39.
Zurück zum Zitat Hullfish KL, Bovbjerg VE, Gibson J, Steers WD (2002) Patient-centered goals for pelvic floor dysfunction surgery: what is success, and is it achieved? Am J Obstet Gynecol 187:88–92PubMedCrossRef Hullfish KL, Bovbjerg VE, Gibson J, Steers WD (2002) Patient-centered goals for pelvic floor dysfunction surgery: what is success, and is it achieved? Am J Obstet Gynecol 187:88–92PubMedCrossRef
40.
Zurück zum Zitat Tamanini JT, D’Ancona CA, Tadini V, Netto NR Jr (2003) Macroplastique implantation system for the treatment of female stress urinary incontinence. J Urol 169:2229–2233PubMedCrossRef Tamanini JT, D’Ancona CA, Tadini V, Netto NR Jr (2003) Macroplastique implantation system for the treatment of female stress urinary incontinence. J Urol 169:2229–2233PubMedCrossRef
Metadaten
Titel
Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy
verfasst von
Christopher R. Chapple
Linda Brubaker
François Haab
Philip van Kerrebroeck
Dudley Robinson
Publikationsdatum
01.02.2007
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 2/2007
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-006-0148-0

Weitere Artikel der Ausgabe 2/2007

International Urogynecology Journal 2/2007 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.